Dr. Antony Burton (Dunad Tx) to Share Insights at the 2nd Proteomics-based Drug Discovery Summit in Boston
- Jan 29
- 1 min read
Dunad Therapeutics is proud to announce a speaker presentation by our Associate Director, Dr. Antony Burton, at the 2nd Proteomics-based Drug Discovery Summit in Boston, MA February 2-4.
You can get a preview of his talk, entitled, “Chemoproteomics discovery of a CNS-penetrant covalent inhibitor of PIKfyve”, on Biorxiv here:
